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Abstract
The abundance of high-dimensional measurements in the form of gene expression and mass spectroscopy calls for models
to elucidate the underlying biological system. For widely studied organisms like yeast, it is possible to incorporate prior
knowledge from a variety of databases, an approach used in several recent studies. However if such information is not
available for a particular organism these methods fall short. In this paper we propose a statistical method that is applicable
to a dataset consisting of Liquid Chromatography-Mass Spectroscopy (LC-MS) and gene expression (DNA microarray)
measurements from the same samples, to identify genes controlling the production of metabolites. Due to the high
dimensionality of both LC-MS and DNA microarray data, dimension reduction and variable selection are key elements of the
analysis. Our proposed approach starts by identifying the basis functions (‘‘building blocks’’) that constitute the output from
a mass spectrometry experiment. Subsequently, the weights of these basis functions are related to the observations from
the corresponding gene expression data in order to identify which genes are associated with specific patterns seen in the
metabolite data. The modeling framework is extremely flexible as well as computationally fast and can accommodate
treatment effects and other variables related to the experimental design. We demonstrate that within the proposed
framework, genes regulating the production of specific metabolites can be identified correctly unless the variation in the
noise is more than twice that of the signal.
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Introduction
Metabolites are the products of cell metabolism and their
functions are highly diverse. The profile of metabolites shows the
current physiological state of a cell and is the end result of the
upstream biological information that flows from the biological
processes going from the genome over the transcriptome and
proteome to the metabolome.
We wish to combine data from transcriptomics and metabo-
lomics into one experimental setup in order to generate hypotheses
about the regulatory processes between different molecular levels.
While the biological processes between different levels of ‘‘omics’’
are highly complex, a combined analysis of metabolite and gene
expression data will help discover and elucidate the underlying
regulatory networks and identify genes that influence the
metabolome because they – directly or indirectly – are involved
in the metabolism.
Gene expression studies measure the simultaneous expression of
up to thousands of genes and can be used to identify which genes
are up- or down-regulated under certain conditions. Metabolomic
studies provide information on the metabolites found within a
biological sample – for example from mass spectrometry data –
and can be used to discriminate between the amount and types of
metabolites in different samples or under different conditions.
These two ‘‘omics’’-approaches address questions at different
biological levels, but they both seek to uncover the underlying
systems biology and when combined they can be succesful in
predicting gene functions or identifying gene-metabolite associa-
tions [1,2].
The idea of coupling data from different aspects of the same
biological system – a term known as integrative analysis or ‘‘multi-
omics’’ – is not new and several recent publications apply this idea
to identify gene function or gene-to-metabolite networks for for
example plant and cancer cells [2–5]. The integrated data analysis
methods all need to reduce the dimensionality of the data (either of
each type of data separately or by combining the two data types
into a single normalized ‘‘dimensionless’’ dataset prior to
dimension reduction) before multivariate correlation analysis,
clustering methods, or for example self-organizing maps are used
to identify groups of associated genes and metabolites [4,6,7].
Other approaches use prior knowledge (e.g., previously identified
regulatory pathways or previously hypothesized gene-metabolite
relationship) to validate findings [6,8]. The recent tool, Mas-
sTRIX, also uses existing annotation information from KEGG
(Kyoto Encyclopedia of Genes and Genomes) to visualize
combined transcriptome and metabolome data [9].
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The references mentioned above typically uses some kind of
correlation measure to describe the association between the two
types of data, but multivariate methods like partial least squares
(PLS) regression have also been used for integrated data analysis
[10]. In PLS, combinations of explanatory variables are computed
and these combinations are subsequently used as predictors in a
statistical model. However, PLS is not without caveats since the
main focus is on prediction and not on identifying the underlying
system and interpreting the effect of individual genes and the
underlying biological system may be difficult at best. When PLS is
applied to full functional mass spectrometry data it results in
components that are a mix of different mass-time combinations so
it is impossible to infer how a set of genes influence a particular
chemical compound and the underlying basis functions often lack
a meaningful interpretation compared to the original data. A
variation of these methods, co-inertia analysis (CIA) is based on
maximizing covariance between PCA (principal component
analysis) components of two separate datasets, which again could
make interpretation difficult [11]. Common for all these methods
is that they try to discover relationships between metabolomics and
transcriptomics data without describing the underlying biological
system except for the fact that the metabolites are the end product
and hence are possibly influenced by one or more genes working
on a level upstream from the metabolites.
In this paper, we will present a statistical modeling approach to
model the association between gene expression and metabolite
development as measured by DNA microarrays and Liquid
Chromatography-Mass Spectroscopy (LC-MS), respectively. The
idea is to use matrix decomposition to identify metabolite
‘‘building block’’ that constitute the observed metabolite profile
data and then combine these results with a multivariate linear
model with the gene expression data as possible predictors
(properly regularized to prevent overfitting). This combined
approach has the nice properties that we are 1) able to identify
which metabolites occur in unison between different experimental
setups, 2) we are able to handle complex experimental designs
through the statistical model, 3) we get information about which
genes are associated with each metabolite as well as the individual
magnitude of their association, and 4) we do not require
information from existing databases on known pathways or
annotations. Thus, our proposed modeling approach can be used
not only to validate previously known gene-to-metabolite networks
but also to uncover new networks for organisms that are less
investigated than, say, yeast or Arabidopsis and to describe the
strength of these relationship. In addition, the underlying
biological assumption that the metabolites are the end product
of a complex biological process is kept in mind because the two
datatypes are not assimilated into a single dimensionless dataset.
Instead, the functional relationship where the gene expression
levels can influence the metabolites forms the basis of the
underlying model.
The paper is structured as follows: in the methods section we
describe how a metabolite matrix decomposition can be combined
with a regularization technique to model the associations between
gene expression and metabolite profile data. The simulation
section describes a simulation setup to show how effective our
method is in identifying the correct relationships between genes
and metabolites for various signal-to-noise ratios. In applications
we apply the method to a Cassava dataset and the results section
presents the results from the simulations and application. In the
discussion we discuss advantages and disadvantages of the
proposed method. Example code for running the analyses in R
and MATLAB can be found at www.biostatistics.dk/ida.
Results
To demonstrate the validity of the proposed method a
simulation study was undertaken. Our primary focus is whether
the approach is able to identify the correct pathways that govern
the underlying relationships among gene expression levels and
peaks in the simulated spectra. We also performed two other
simulations to examine the robustness of the method. In one
scenario we increased the number of genes, while the other
investigated how the method performs if no associations between
genes and peaks in the spectra are present. Each combination of c
peaks and 7 noise levels was run 300 times and the results are
shown in Figure 1. A decomposition with ‘‘number-of-peaks +1’’
components was used and the resulting mixing matrix was
subsequently used as response in ‘‘number-of-peaks’’ models with
the expression from 1000 simulated genes as predictors. The first
selected gene from each model was compared with the gene
known to be associated with the component, and if it did not
match perfectly it was scored as an error. The percentage of the
300 simulations that resulted in errors is our error/misclassifica-
tion rate. Each line in the figure represents a setup with a given
number of peaks and the percentage of incorrectly classified genes
are shown for shown for various signal-to-noise ratios (SNR)
ranging form 52 to 0.1. Note that the x-axis in Figure 1 is on a log
scale to better differentiate the results for both low SNRs and high
SNRs.
The percentage of correctly classified genes was very high, more
than 95% on average when the SNR was higher than 5. With a
SNR of 52 the correct genes were identified in 97.6% on average
of all cases, ranging from 99.7% with 5 peaks to 93.2% with
15 peaks, decreasing slightly to 97.1% and 95.3% for SNR 16 and
6, respectively. From SNR 2.5 the percentage of correctly selected
genes decreased more rapidly from 88.6% to 74.1% SNR 1.4,
53.9% SNR 0.5 and 38.9% for SNR 0.1.
Increasing the number of peaks generally resulted in larger error
rates while the effect of noise appears independent of the number
of peaks. This was most notable with high SNR. For lower SNR,
this trend became less clear, in fact with SNR 0.5 the order of the
lines corresponding to different number of peaks changed order:
the error was 43.7% with 5 peaks and 43.5% with 15. The effect of
lower SNR can be seen in Figure 1, from SNR 52 to 6 mean errors
are below 5% with range about 7%. From SNR 2.5 to 0.1 the
effect of noise appears non-linear, and error range increases to
31.8%.
Figure 1. Results of simulation study. Each line represents the error
rate for various signal-to-noise ratios for a given number of peaks in the
simulated spectra. Each combination of peaks and noise ratio was run
300 times. x axis on log scale to help visualization.
doi:10.1371/journal.pone.0072116.g001
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The effect of increasing the number of genes from 1000 to
25000 can be seen in Figure 2. More genes does decrease the
precision of the model in particular when the number of genes is
low. However, as soon as the initial number of genes is large (5000)
then the noise in the data is far more influential on the error rate
than the number of genes. With SNR 6 the error went from 0.3%
using 5000 genes to 0.8% with 25000 genes. With lower SNR the
effect of more genes affected the performance to a higher degree,
with SNR 0.5 the error ranged from 8.2% to 43.6%. The effect of
increasing the number of genes from 1000 to 25000 can be seen in
Figure 2. More genes does only decrease the precision of the
model slightly, however the noise in the data is substantially more
influential. With SNR 6 the error went from 0.3% using 1000
genes to 0.8% with 25000 genes. With lower SNR the effect of
more genes affected the performance to a higher degree, with
SNR 0.5 the error ranged from 8.2% to 43.6%.
Finally we wanted to investigate the performance of the model
when no associations between genes and peaks in the spectra are
present. We did this by generating data as previously described
with 10000 genes, a SNR of 20 and 5 peaks. After generating the
spectra we removed the 5 influential genes, and used a random
subset of 1000 genes from the remaining 9995. Following gene
selection by LARS we fitted a multiple regression model with the
selected genes in order to obtain a p-value for the gene selected
first by LARS. This procedure was run 300000 times. Out of the
possible 9995 genes, only 475 genes were among the first selected
genes with a frequency ranging from 1 to 30199 times (mean 3158
and standard deviation 6365). Few genes (87) were selected more
than 5000 times and only 5 of 9995 were selected approximately
30000 times. The average p-values from the multiple regression
model was 0.49 with standard deviation 0.11. P-values centered
closely around 0.5 and few genes selected very often indicates that
the method is robust against unfortunate subset compositions.
Shrinkage methods do not produce p-values and therefore the
strength is not known. The genes selected are the best ones even if
selected from a set with no associations to the response. However
this result suggests that variable importance can be employed to
quantify the significance of the found association.
As mentioned previously the results from the analysis are
directly interpretable with respect to the original data. Assume, for
instance, that one sample like the the upper left panel in Figure 3
corresponds to one biological sample out of several. At the end of
the analysis we know how the individual components/features
look, their positions as described by retention time and m=z makes
it possible to identify the metabolic compounds that represent the
peaks in the LC-MS spectra. For example, the red colored basis
function in Basis A and B can easily be identified in the original
spectra as the peak furthest to the left. At the same time we know
the weights of all the basis functions required to reconstruct the
original samples. Using the corresponding mixing component (also
in red) we are able to find genes associated with that specific peak.
Discussion
The underlying assumption in our setup is that the gene
expression levels may influence the downstream production of
metabolites. We have clearly demonstrated that within this
framework, genes regulating the production of specific metabolites
can be identified even though the proposed method uses very few
assumptions. In that sense, our approach resembles unsupervised
learning techniques since we both extract possible basis functions
from the spectra data and identify associations between the
weights of the basis functions and the gene expression levels.
In the simulation study we achieved very high accuracy in
identifying the genes known to control the peak heights (metabolite
content) in the generated spectra. As expected, the accuracy was
was highest when the signal-to-noise ratio was high and the error
rate was less than 20% until a ratio around 2. Even when the
signal-to-noise ratio is less than one the error rate generally is less
than 60%.
Not surprisingly, the performance of the model decreases when
more peaks are present (see Figure 1). This is a result of poorer
separation by parallel factor analysis (PARAFAC), which is to be
expected as partial or even full peak overlaps become more
frequent. Note that explained variation can still be high even if
separation of the tensor into the original components is poor, in
the sense that the estimated components do not resemble the
original components. This can occur if the estimated components
are mixtures of true components or mixtures of noise and true
components. The simulated spectra were notably smaller (R40|30)
than most real-world spectra purely to reduce computing time for
the simulations. In practice the peaks will be distributed over a
larger surface, resulting in greater separation performance in most
experiments.
For high SNRs there was a clear trend of larger error rate with
more peaks. This trend is obscured when SNR reaches approx-
imately 1, i.e. when the variation in signal and noise is of the same
magnitude. At this point the performance of the PARAFAC
separation becomes less influential than the noise added to the
gene expression before modeling.
The variation of the model precision must increase with the
magnitude of the noise added to the simulated gene expression
data. However, the impact of this will be low since gene expression
data from real experiments can to some extent be cleaned of noise
and often exhibit relatively low noise compared to the values tried
in our simulations [12].
The number of components for the PARAFAC model, c, should
be carefully selected to ensure that the mixing matrix does indeed
represent the mixing of individual chemical compounds. With
simulated data this is trivial as the true number of components is
known. With real data this can be a daunting task if the peaks in
the spectra are very dense. Too many components will mean that
more than one component will describe a single feature, while too
few will result in components that describe more than one feature.
It is worth noting that a PARAFAC model with ‘‘sufficient’’
components might return basis functions that capture more than
one feature. In this case the genes selected by the analysis are
assumed to influence all features in the original spectra. We argue
that it is not unreasonable to assume that a useful separation can
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Figure 2. Results of simulation study. All simulations used 5 peaks
and was run 300 times for each combination of noise and genes.
doi:10.1371/journal.pone.0072116.g002
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be achieved, and in any setting, decompositions of this type require
a qualified estimate of the number of components. A first step is
likely to be a visual inspection of the spectra followed by fitting a
few models with different (but not much) components. Optimiza-
tion of the number of factors has received some research interest,
[13] and [14] both propose algorithms to aid in the selection. In
extreme cases it might be worthwhile to divide the original tensor
of (aligned) spectra into a number of sub-tensors and apply the
proposed model to each of these. Preprocessing such as alignment
and baseline correction can also aid in reducing the error.
In this paper, we have used PARAFAC to decompose the
metabolomics data and least angle regression (LARS) to reduce
the dimension of the gene expression data. However, essentially
we have formulated a framework which accommodates different
methods for both the decomposition and the covariate selection.
Any method that can decompose the metabolite data could in
principle be used for the matrix decomposition and any
regularization method could be used for the covariate selection.
This leaves the investigator with a large and flexible toolbox where
the choice of method should be based on which qualities of the
methods that are relevant for the situation at hand.
We used LARS for regularization partly because of its speed,
partly because it scales well with increasing number of gene
expressions, and partly because the least angle regression
regularization technique fits directly into our linear model
framework shown in (3). When multiple genes are involved in
the regulation of metabolite production several of the correspond-
ing gene expression profiles could have very similar expression
patterns. In this case, even if all are influential then LARS will tend
to select only one of the genes from this set at random while setting
the coefficient of the remaining genes to zero. An alternative
would be to use OSCAR (octagonal shrinkage and clustering
algorithm for regression) which tries to address this issue by
performing selection and clustering of correlated predictors
simultaneously [15]. OSCAR assigns coefficients to all predictors
in the model, which can then be ranked by the size of the assigned
coefficients. Likewise the clustering is performed by assigning
nearly identical coefficients to co-selected genes.
A disadvantage of our proposed method (as well as other
variable selection methods) is that we consistently consider the first
selected gene regardless of its strength or significance. Thus, we
are guaranteed to find the ‘‘best association’’ from the available
data but is unable to directly infer if an association appears to be
stronger than what could be expected by chance. Our simulation
results indicate that a variable importance approach based on
resampling can be used to determine the strength of an
association. One way to investigate the robustness of a result
would be to run the analysis several times with different subsets of
the genes, in the same way as with simulated data. If the same
genes are selected irrespective of the subset they appear in, one
would be more inclined to trust the effect of these genes to be
‘‘true’’ [16].
Multi-way models are not quite as numerous as shrinkage
models, but alternatives to PARAFAC are available. Tucker
Figure 3. Example of simulated spectra with 5 peaks. Each peak height is controlled by a the expression level of a specific gene. Background is
random normal noise. The simulation study used 10 replicates to construct the Y tensor, one is shown in the upper left panel. PARAFAC
decomposition of the simulated spectra, a 6 component (5 for the peaks and 1 for the noise) model was used. In a real-world application basis A and
B, would be used to identify the compounds in the sample based on their combination of retention time and m=z value. Basis C is used as response
in a regression model with gene expressions as predictors, and for each sample unit a relative weight of the of the components can be seen.
doi:10.1371/journal.pone.0072116.g003
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models are often used to compensate for base shift in spectra [17].
However, we assume that the data has been sufficiently pre-
processed for the metabolite spectra to comparable before
analyzing the data so this is not a huge advantage. Non Negative
Tensor Factorization (NTF) is a generalization of Non Negative
Matrix Factorization aimed at retrieving underlying components
from high dimensional data [18]. The basic formulation NTF is a
PARAFAC model with non-negativity restrictions, while the
extensions NTF1 and NTF2 produce different dimensional
output, most importantly one matrix and one tensor, while
PARAFAC produces three matrices [19]. The mixing matrix can
still be extracted for the NTF1 and NTF2 extensions so NTF-
based methods would all be potential alternatives within our
framework. However, at this moment the computation time can
be prohibitive so in practice we have to wait for some faster
general purpose graphics processing unit implementations of NTF
that are underway [20].
Although other studies attempt to model associations between
genomic and metabolic data, none of these are directly compa-
rable to what we present in this paper as they use data in different
forms as well as incorporating prior knowledge [4,6–8]. Methods
based on PCA or PLS cannot be directly compared to our
proposed method as the original data is reduced to components
that are a mix of variables so it is impossible to infer a specific
relationship between a single gene and a metabolite profile unless
the principal components split up very advantageously [10,11].
Unlike many other methods, the modeling framework proposed
here does not make use of prior knowledge and have very few
assumptions, which makes analysis of less studied organisms more
approachable.
In conclusion, the method presented here successfully embraces
the complex structures of modern high resolution analysis
machinery. Our proposed model imposes few restrictions on the
association between the two datasets and is more flexible than
models based on correlation measures [7]. This allows for a more
complex relationship between transcription and metabolite
production. We also allow the model formulation to include more
complex (e.g. interaction) terms without altering the basic concept.
Each individual data type (spectra and gene expression) can be
utilized to full extent and we can bridge the gap between
transcriptomics and metabolomics in order to provide information
as to which specific genes are involved in the underlying system
pathways. This is a promising direction for large-scale analysis in
the future, potentially eliminating separate modeling of different
data types that essentially are part of the same system. The ability
to choose different methods for dimension reduction and modeling
as well as inclusion of treatment or other external variables makes
this approach very flexible and applicable throughout the
biological sciences.
Methods
We wish to construct a statistical model that can model the
observed metabolite data as a function of the observed gene
expression data.
Apart from measuring two aspects of the same system, the two
methods also produce different sized output, which is briefly
described below. The metabolite data are assumed to arise from
an LC-MS experiment, where the liquid chromatography
separates the chemical compounds and measures elution time
while the mass spectroscopy fragments the eluded compounds into
smaller molecules summarized by their mass/charge ratio, m=z.
For each combination of elution time and m=z value, an intensity
representing the amount of a given metabolite is measured. Thus,
for a single experimental unit the resulting metabolome data can
be represented as a matrix where each column represents a specific
elution time, each row a particular m=z value, and the values in
the data matrix are the observed intensities. The metabolome data
from a single experimental unit can therefore be visualized as a
three-dimensional plane with intensities giving the z values. An
example of such a plane is shown in Figure S1. Several samples
will result in a three-dimensional tensor Y[Rmz|elution time|samples
that will be part of our outcome/response data.
Gene expression studies measure the expression of thousands of
genes simultaneously. Microarray experiments, for example, emit
light proportional to the amount of RNA bound at a specific probe
when excited by a laser, and the resulting image is converted to
numeric values for expression. The data structure from such an
experiment for a single experimental unit is a vector of expression
values – one for each gene/probe. For several experimental units
in a sample the full expression data can be combined into a data
matrix where each row represents a gene/probe and where each
column represents an experimental unit. The values in the gene
expression matrix is then the observed expression levels, and each
row will therefore act as a possible predictor in our scenario.
Let n be the number of experimental units and assume that for
each experimental unit data is obtained on both metabolic spectra
as well as on gene expression levels. The three-dimensional tensor
Y[Rr|k|n represents the values from the observed metabolic
spectra from n experiments measured at k time points and at r
m=z values and the two-dimensional tensor X[Rn|m represents
the corresponding observed gene expression values from m genes
based on the n experiments. Note the 1:1 correspondence between
the number and order of the units from the two datasets: nmust be
identical for both the metabolic spectra and the gene expression
data for the approach to be meaningful.
We wish to model the expected metabolic spectra as a function
of the gene expression levels in order to determine which genes are
influencing the spectra, i.e., such that
(Y)is a function of Xb, ð1Þ
where b[Rm is a set of parameters describing the effect of each of
the individual genes. If we can identify a set of genes with large
coefficients then that set has an impact on the underlying
biological system that produces the metabolic spectra.
The formulation in (1) poses two major problems: First, the
dimension of the matrices comprising Y is typically extremely
large compared to the number of experimental units, n, and at best
we can only hope to identify and model the primary trends
observed in Y. Consequently, we need to extract the primary
components that constitute the observed spectra and model those
as a function of the observed gene expression levels. Secondly,
classical multiple regression techniques will fall short even if we are
able to extract a set of spectra components to use as outcomes
since the number of genes, m, is also very large relative to the
number of experiments, n. Hence, we need to apply dimension
reduction techniques on both Y and X to extract the important
aspects of the two types of data and to be able to model the
relationship between the spectra, Y, and the gene expression
profiles, X.
Here, we suggest to decompose the spectra data, Y, using
PARAFAC to produce a three-way decomposition with c
components [21,22]. The number of desired components, c, is
chosen by the investigator and the decomposition produces
matrices, A,B, and C such that Y&
Xc
i~1
Ai0Bi0Ci, where
C~½C1D    DCc[Rn|c is called the mixing matrix, and where
Genetic Regulation of Metabolites
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A~½A1D    DAc[Rk|c and B~½B1D    DBc[Rr|c can be inter-
preted as basis functions for retention time and m=z values,
respectively. A and B can be seen as the underlying building blocks
of the mass spectrometry data in the sense that each column of A
and B represents a building block profile, while C provides the
amounts of each building block that is necessary to reconstruct Y.
The available gene expression values act as possible predictors
in model (1), but since the number of genes, m, typically is orders
of magnitude larger than the number of observations, n, we need
to make some kind of regularization on the regression parameters
in order to prevent overfitting and to account for possible
collinearity so we are able to identify a subset of genes of interest.
Here we suggest to use least angle regression (LARS) as a way to
apply constraints on the coefficient matrix of the model [23]. Least
angle regression has the advantage that it is computationally very
fast and that two predictors obtain coefficients that behave in the
same way when they are equally correlated with the response.
Thus, we can use LARS to select a small subset of genes from
thousands of gene expressions and identify how they influence the
mixing components of the spectra.
Our modeling idea is to employ two dimension reduction
techniques: One to decompose the spectra into components that
include basis functions and a mixing matrix and one that imposes
restrictions on the vector of parameters b such that all parameters
do not enter the model at the same time. Consequently, we can
rephrase our model (1) as a set of c regression models (one for each
of the mixing components):
Ci~XbizEi for i~1, . . . ,c ð2Þ
with bi subject to some restrictions
where we essentially model the mixing or weight of the basis
functions as a function of the observed gene expression levels.
Each Ei vector is assumed to follow an independent Gaussian
distribution with mean zero and variance s2i In. The restrictions
applied to bi is due to prevent overfitting as defined by the least
angle regression [23].
Our primary interest is to identify any associations between the
gene expression data and the metabolic profiles data so model (2)
can be illustrated as shown in Figure 4a. Model (2) is extremely
flexible, however, and we can easily include additional predictors
based on the experimental design. If, for example, some of the
experimental units were assigned to special treatment groups or
belonged to specific genetic strains then we would like to model the
effect of these external covariates. Two possible situations exists:
either the external variables influence both the gene expression
levels and the metabolic profiles (corresponding to the diagram
shown in Figure 4d) or the variables may influence only the
metabolic profiles (see Figure 4c). The former situation is often
more realistic and corresponds to the situation where the external
variables act as confounders. In either case, we can easily include
external variables pertaining to the experimental design in our
model when modeling each of the c components in order to
control for them by adding them to the model:
Ci~XbizX
0bi
’zEi for i~1, . . . ,c ð3Þ
with bi
’ subject to some restrictions
Here, the extra design matrix X0 with corresponding parameters
bi
’ represents the external variables. Finally, the model also
accommodates situations where external variables act as effect
modificators of the gene expression levels (i.e., the external
variables change the effect of the gene expression data, see
Figure 4b). That situation is handled by including an interaction
between the gene expression data and the external variable in
model (3). If the primary hypothesis of interest is how the external
variables influence the metabolite profiles then the interaction can
be used to answer that as well.
To summarize, our proposed approach consists of two stages:
1. Decompose the n spectra into c basis functions for retention
time, A, and m=z values, B, and the mixing matrix C.
2. Fit each of the c estimated mixing components as function of
the observed gene expression values using a multiple linear
regression model approach that accommodate overfitting (i.e.,
can handle more regressors than observations).
In this paper we use parallel factors analysis (PARAFAC) to
provide the three-way decomposition of the Y tensor while least
angle regression (LARS) will be used for shrinkage regression and
subset selection on the set of b parameters from X. Other methods,
like singular value decomposition, or non-negative tensor factor-
ization for the metabolome data decomposition and ridge
regression, or OSCAR (octagonal shrinkage and clustering
algorithm for regression) for the shrinkage of the gene expression
data could essentially be applied as well depending on a given
situation. We consider alternative choices further in the discussion.
If an association between a gene expression level and a mixing
component (i.e., a b coefficient is found to be non-zero for one of
the c regression models) then that suggests that the corresponding
gene is associated with the metabolites corresponding to the peaks
in the relevant basis functions. For example, if we analyze, say,
mixing component C2 and find that b3 is non-zero for that
component then this suggests that gene 3 influences the weight of
basis functions A2 and B2. Basis function B2 consists of a full
metabolite profile so gene 3 will be associated to the full metabolite
profile, but since the matrix decomposition separates the profiles
based on the peaks in the spectra we essentially have that gene 3 is
associated to the peaks (and the corresponding metabolites they
represent for a given m=z value) found on basis function B2. The
same is true for basis function A2. An important feature of the
tensor (spectra) decomposition is that the two basis functions A
and B retain the x-values of the original spectra. Subsequently, a
GE MP
(a)
GE× EV MP
(b)
GE MP
EV
(c)
GE MP
EV
(d)
Figure 4. Relevant models when integrating gene expression
and metabolic profile data. ‘‘GE’’, ‘‘MP’’ and ‘‘EV’’ correspond to
gene expression data, metabolic profile data, and external variables,
respectively. The dashed lines represent the primary focus of interest:
the association between gene expression levels and metabolic profiles
while the solid lines represent possible associations between the
available data.
doi:10.1371/journal.pone.0072116.g004
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table of compounds corresponding to the peaks found in the basis
functions can be produced and metabolite databases such as
Metlin can then be searched for compounds with these attributes.
Thus, the individual component characteristics are intact and both
chemical compounds of interest and the genes controlling their
production can be identified from the model.
Simulations
A simulation study was undertaken to demonstrate the validity
of the proposed method, and data were generated as described
below. Background and treatment effects were all arbitrarily
chosen to create a data structure resembling what might be
observed with real data, but the numbers have no further
interpretation. Artificial treatments were constructed to make the
gene expression data resemble what could be observed by using
different experimental conditions. We assume that measurement
error such as variation between microarrays, retention time shifts
can be remedied by pre-processing and do not impose these on the
simulated data.
The simulation procedure was as follows:
1.
(a) Gene expression data resembling output from a DNA
microarray experiment were generated first. In this case we used
n~10 biological replicates and m~1000 genes to represent the
results from a small DNA microarray chip. The average
expression level for each gene was drawn from a Gaussian
distribution with mean 500 and standard deviation 4, N(500,42).
These 1000 simulated gene levels background were repeated 10
times to form the replicates.
(b) To simulate three groups of genes: up-, down-, and
unregulated, we applied two different background levels (+225
and 2180), to 400 and 500 randomly selected genes (rows)
respectively. Secondly, two treatments (+100 and 2320) were
applied to 5 and 4 randomly selected replicates (columns)
respectively. Finally Gaussian noise with standard deviation 100
was added to all observations, and absolute values used. Note that
the up-, and down-regulated genes have an effect of approximately
2 standard deviations.
2.
(a) c basis spectra Basis1, . . . ,Basisc, Basisi [R
40|30, each
containing one peak were generated by first simulating random
Gaussian N(0:05,0:12) background noise. The coordinates of the
peaks were found by randomly drawing c positions and they were
sorted to make subsequent matching simpler. At each position a
Gaussian N(10,12) density replaced the original values to create a
building block peak.
The dimension was arbitrarily chosen but kept small to make
computations fast, and c was varied in the following from 5 to 15
to represent different complexities in the spectra. We chose to let
one peak represent the rows normally seen i LC-MS as these can
be assume to arise from the same compound.
(b) Each basis spectra was scaled by the first c genes, e.g., in the
case of 5 basis spectra, the expression levels of each of the first 5
genes would influence the height of each of the 5 peaks in the
‘‘observed’’ spectra, thus, the observed spectra for sample i is given
by
Yi~
Xc
j~1
xij :Basisj ,
where xij is the gene expression level from gene j from sample i.
An example of a simulated spectra is shown in Figure 3. The
scaled basis spectra, Yi, were combined to make a 3-D tensor
[R40|30|10
After simulation of the gene expression and metabolic data we
applied the proposed method to see if we could identify which
genes that are associated with each of the peaks in the metabolic
spectra.
1. The simulated spectra were separated into basis and mixing
matrices with a PARAFAC model using cz1 components.
The extra component is meant to capture the background
noise of the spectra. In practice, the true number of
components, c, is not known but the number of peaks can be
visually determined from the spectra, so it is not an
unreasonable assumption that c is known.
2. Seven different noise levels were applied to the simulated DNA
microarray data to represent measurement error from the gene
expression experiment. At each noise level, Gaussian noise with
a standard deviation ranging from 0 to 60 in steps of 10 were
added to X prior to using the data for gene identification in the
LARS model (but after the true gene expression level had been
used to influence the peak height).
3. Finally, the mixing matrix was used as response in c LARS
regression models where the ‘‘noise component’’ from the
decomposition is disregarded.
The first selected gene was compared to the true gene for each
LARS model. PARAFAC does not retain the order of the peaks,
thus the components of the mixing matrix were sorted according
to the corresponding peak order of the basis matrix, B[R30|c.
This ordering is purely to ensure that we can verify if the correct
gene is matched with the correct peak as per step 2 (c) above.
This setup allows for rapid calculations and the LARS model
produces compact output which is ideal since only the first gene
selected by each of the LARS models is of interest in this study (i.e.,
for the j’th component we hope to find bj as the first selected
gene). Explained variation in the PARAFAC decomposition was
very high in all cases, 95{99%. We quantify the noise added to
the gene expression using (4), where s2x is the variance of the
simulated gene expressions, s2u is the variance of the added noise, s
is the residual error from the LARS model and b is the matrix of
coefficients from the LARS model.
Signal to Noise Ratio (SNR)&
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
s2xb
Tb
q
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
s2ub
Tbzs2
q ð4Þ
Our initial parameters for the simulation results in s2x~86342,
s was found to be between 7:5|10{3 and 3|10{1 and bTb was
between 8|10{7 and 7|10{10. The calculated SNR values are
found on the x-axis of Figure 1. A SNR value of 1 corresponds to
equal variation in gene expression and background.
Application
We applied the method to a Cassava (Manihot esculenta) dataset
with 32 samples of leaf material of both LC-MS and single-color
microarray data. Cassava is an important tuber crop in Africa,
Asia and South America but due to its content of the toxic
cyanogenic glucosides extensive processing is required before
consumption. In spite of its socio-economic importance and
identification of some of the processes in the catalyzation of
cyanogenic glucosides [24] many pathway steps are yet
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unidentified. Likewise, gene annotation is far from complete;
Roughly 3% of the genes in Phytozome (May 2013) are labeled
‘unknown protein’, and 15% have no annotation. Thus
identification of genes associated with the compounds of interest
could target potential areas of interest, which might eventually
lead to non-toxic varieties.
Of the 32 samples, two samples were disregarded due to
insufficient quality. A control sample revealed the region of
interest in the LC-MS spectra, an example of which is shown in
Figure S1. The 30 individual spectra shoved little variation with
regard to peak height. After cropping and combining the spectra,
the resulting dimension was R30|451|371. Gene expression of
13865 genes of which 30% were not annotated were measured in
the microarray experiment for each of the 30 samples. The
expression data was used without any preprocessing, such as
normalization or alignment.
A three component PARAFAC model explained 90.71% of the
variation in the LC-MS spectra. This was expected as 3 major
peaks can be visually identified in the spectra (see Figure S1).
Following our approach from the simulation study, a four
component model would have been ideal, however the signals in
the spectra was much stronger than in the simulated data. Thus,
an additional component would not capture the noise but be a
replicate of one of the other three components. Each column of
the 30|3 mixing matrix was subsequently used as response in 3
LARS models with all 13865 genes as potential predictors.
The first peak in the spectra was identified as Linamarin, a well-
known compound in Cassava. The LARS regression selected a
gene involved coupled to several CYP79 enzymes, which has been
identified as a catalyst in the synthesis of Linamarin in Cassava
[24]. With further study we hope to identify one of the other peaks
as Lotaustralin and using the selected genes to further elucidate its
synthesis pathway.
Supporting Information
Figure S1 LC-MS data, one biological sample. Ea-
ch\row’’ of peaks, illustrated by the red line, corresponds to a
molecule fragmented into smaller parts. The width of the red line
is exaggerated, as a single time point would be to narrow to be
seen. Often one such row consists of many small peaks, and are
analyzed one at a time.
(EPS)
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